Skip to main content

Table 2 Distribution of the CCND1, MHC-I and antigen-presenting related gene expression, and their spearman correlation

From: BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer

 

CCND1 (N = 1088)

Variable

N

Median

Range

Correlation (95% CI)

p value

T cell activation score

   

−0.17 (− 0.22, − 0.11)

< 0.0001

HLA-A

1088

14,636

1290–186,441

− 0.26 (− 0.32, − 0.21)

< 0.0001

HLA-B

1088

22,385

2013–373,873

− 0.27 (− 0.33, − 0.22)

< 0.0001

HLA-C

1088

16,592

1455–224,187

− 0.21 (− 0.26, − 0.15)

< 0.0001

ERAP1

1088

1416

94–7157

0.05 (− 0.01, 0.11)

0.109

ERAP2

1088

643

4.5–6506

−0.08 (− 0.14, − 0.02)

0.0098

TAP1

1088

2259

205–41,853

− 0.26 (− 0.31, − 0.20)

< 0.0001

TAP2

1088

1148

117–15,665

−0.30 (− 0.35, − 0.24)

< 0.0001

TAPBP

1088

5193

1307–24,371

−0.16 (− 0.21, − 0.10)

< 0.0001

CCND1

1088

7925

129–245,328

 Â